These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 6759027

  • 21. Barriers to conception and disease.
    Donovan B.
    Ann Acad Med Singap; 1995 Jul; 24(4):608-14. PubMed ID: 8849197
    [Abstract] [Full Text] [Related]

  • 22. New condoms for men and women, diaphragms, cervical caps, and spermicides: overcoming barriers to barriers and spermicides.
    Hatcher RA, Warner DL.
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):513-21. PubMed ID: 1504271
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. ["In vivo" efficiency of chemical spermicides studied by postcoital vaginal sampling].
    Commerot J.
    Contracept Fertil Sex (Paris); 1974 Mar; 2(2):105-7. PubMed ID: 12229458
    [Abstract] [Full Text] [Related]

  • 25. [Vaginal contraception: mechanical or chemical?].
    Monard S.
    NPN Med; 1983 May 02; 3(50):591-6. PubMed ID: 12313043
    [Abstract] [Full Text] [Related]

  • 26. [Natural Family Planning methods and Barrier: CNGOF Contraception Guidelines].
    Hassoun D.
    Gynecol Obstet Fertil Senol; 2018 Dec 02; 46(12):873-882. PubMed ID: 30389545
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK, Baker JM, Barr SP, Johanson WM, Archer DF.
    Contraception; 1997 Aug 02; 56(2):97-102. PubMed ID: 9315418
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nonprescription vaginal contraception.
    Edelman DA.
    Int J Gynaecol Obstet; 1980 Aug 02; 18(5):340-4. PubMed ID: 6110578
    [Abstract] [Full Text] [Related]

  • 31. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections.
    Niruthisard S, Roddy RE, Chutivongse S.
    Lancet; 1992 Jun 06; 339(8806):1371-5. PubMed ID: 1350804
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Choosing condoms.
    Billow JA.
    Am Pharm; 1992 Sep 06; NS32(9):55-8. PubMed ID: 1442556
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Barrier contraceptives.
    Connell EB.
    Clin Obstet Gynecol; 1989 Jun 06; 32(2):377-86. PubMed ID: 2663278
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The Prentif contraceptive cervical cap: acceptability aspects and their implications for future cap design.
    Koch JP.
    Contraception; 1982 Feb 06; 25(2):161-73. PubMed ID: 7075189
    [Abstract] [Full Text] [Related]

  • 40. Counseling for barrier methods.
    Guest F.
    Health Educ Bull; 1979 Aug 06; ():1-4. PubMed ID: 12311791
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.